October 16, 2026, 9:00 a.m.
Dr. Li's research focuses on molecular pathways controlling innate immunity and inflammation, dynamic programming of innate immune leukocytes, and pathogenesis of acute and chronic inflammatory diseases such as sepsis and atherosclerosis.
HKRB 150